Oklahoma State OG Larry Williams awaits NCAA decision on medical redshirt

Oklahoma State guard Larry Williams experienced something rare on Thursday.

The former East Carolina transfer, who battled injuries in 2016 and 2017 at Oklahoma State, participated in the Cowboys’ 2018 pro day. There’s a still chance Williams could be back with the Cowboys, however, next season.

Williams is seeking a sixth year of eligibility after playing in only three games last season. He won’t know the NCAA’s decision on his medical redshirt until April 18 and had to receive special permission to participate in Oklahoma State’s pro day, according to The Oklahoman’s Scott Wright.

While Williams, who hasn’t signed with an agent yet, was able to make an impression with NFL scouts in Stillwater, he’ll be happy to return for a sixth year of college football if the NCAA grants him the extra season.

From The Oklahoman:

“If I get the year, I want to come back, but if someone gives me a shot at the NFL, like on a practice team or anything like that, I think I’ll just move on,” [Williams] said. “It really just depends on where the cards lay an how things turn out this next month.”

Williams was injured during Oklahoma State’s game against TCU in 2017. He suffered a broken ankle, which forced him to miss the rest of the Cowboys’ season.

Williams was an integral part to the Cowboys’ offensive line before his injury. His return would undoubtedly be a huge boost to Oklahoma State’s offensive attack that must replace its starting quarterback and a few skill players.

For more on Williams’ status, go to NewsOK.com.

The post Oklahoma State OG Larry Williams awaits NCAA decision on medical redshirt appeared first on Diehards.

Thank you for reading the Springfield News-Sun and for supporting local journalism. Subscribers: log in for access to your daily ePaper and premium newsletters.

Thank you for supporting in-depth local journalism with your subscription to the Springfield News-Sun. Get more news when you want it with email newsletters just for subscribers. Sign up here.